The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Loan | Alive

Total Raised


Last Raised

$680K | 2 yrs ago

About Kurin

Kurin develops blood culture collection technology focusing on the contaminants originating in the patient's own skin, which challenge hospital efforts to address false-positive blood cultures. Standing guard between the venipuncture site and the culture bottle, the Kurin Lock diverts the initial blood flow that may contain microbes from deep within the skin. A clinically-relevant blood sample then bypasses the contaminants locked within the device.

Kurin Headquarter Location

10755 Scripps Poway Parkway No. 257

San Diego, California, 92131,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kurin

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kurin is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,167 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,900 items

Kurin Patents

Kurin has filed 15 patents.

The 3 most popular patent topics include:

  • Blood tests
  • Intensive care medicine
  • Blood
patents chart

Application Date

Grant Date


Related Topics




Blood tests, Blood, Intensive care medicine, Hematology, Medical equipment


Application Date


Grant Date



Related Topics

Blood tests, Blood, Intensive care medicine, Hematology, Medical equipment



Latest Kurin News

Kurin, Inc. Announces Launch of Its Proprietary Push-button Needle System

Feb 23, 2022

February 23, 2022 06:00 AM Eastern Standard Time SAN DIEGO--( BUSINESS WIRE )--Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets announced that they have commenced the commercial launch of their push-button needle, to be used as part of Kurin blood culture sets. The Advance Safety Needle System was tested in 2021 and is now being sold into accounts using Kurin. “We are proud to commercialize the Advance Safety Needle, as there has been market demand for alternatives and improvements in this space,” said Bob Rogers, CEO of Kurin, Inc. “We are pleased with our field trials performed over the past several months. In addition to the positive feedback that we received, our testing shows improved performance characteristics compared to traditional, retraction-oriented products. The development of the Advance Needle is an important milestone for Kurin, providing us a more reliable supply of product, better cost control, the opportunity to offer improved benefits over current needles, and creates new strategic opportunities in which we are already engaged.” Kurin’s revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Kurin is a simply better and more sustainable approach over conventional mechanical diversion. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and the life-threatening C. diff. infection. About Kurin, Inc. Kurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at . Contacts

Kurin Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Kurin Rank

  • Where is Kurin's headquarters?

    Kurin's headquarters is located at 10755 Scripps Poway Parkway, San Diego.

  • What is Kurin's latest funding round?

    Kurin's latest funding round is Loan.

  • How much did Kurin raise?

    Kurin raised a total of $3.08M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.